TY - JOUR
T1 - GeneXpert MTB/RIF version g4 for identification of rifampin-resistant tuberculosis in a programmatic setting
AU - Osman, Muhammad
AU - Simpson, John A.
AU - Caldwell, Judy
AU - Bosman, Marlein
AU - Nicol, Mark P.
PY - 2014/2/1
Y1 - 2014/2/1
N2 - A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity.
AB - A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity.
UR - http://www.scopus.com/inward/record.url?scp=84893120416&partnerID=8YFLogxK
U2 - 10.1128/JCM.02517-13
DO - 10.1128/JCM.02517-13
M3 - Article
C2 - 24478501
AN - SCOPUS:84893120416
VL - 52
SP - 635
EP - 637
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
SN - 0095-1137
IS - 2
ER -
